Dear Allen,
you example shows that the rms value will be NA when the count is
zero.
Surprisingly, there was one example where the rms value is NA and the
count
value was non-zero. I will have to investigate why this occurs.
As outlined in section 7.7. transformation of of the rms values has
been
disabled since MEDIPS. >= 1.10.0.
Lukas
On Mon, Sep 15, 2014 at 3:20 AM, Chong Kim San Allen
<patcksa@nus.edu.sg>
wrote:
> Dear Lukas,
> I went back and tried to find those with Inf but I can't. I don't
remember
> where I put the files that contained those values.
>
> I did however find those that contained the NA values and I have
attached
> the file containing some of these.
>
> I was thinking whether I should use the "transf" parameter so as all
> values are set to between 0 and 1000 for RMS. Perhaps this would not
give
> the NA or Inf values
>
> Thanks,
> Allen
> ________________________________________
> From: Lukas Chavez [lukas.chavez.mailings@googlemail.com]
> Sent: Saturday, September 13, 2014 1:12 AM
> To: Chong Kim San Allen
> Cc: Allen [guest]; bioconductor@r-project.org; MEDIPS Maintainer
> Subject: Re: [BioC] MEDIPS: how does MEDIPS define a methylated
region /
> cluster?
>
> Dear Allen,
>
> please see my comments below.
>
> Best,
> Lukas
>
> On Fri, Sep 12, 2014 at 3:00 AM, Chong Kim San Allen
<patcksa@nus.edu.sg> <mailto:patcksa@nus.edu.sg>> wrote:
> Dear Lukas,
> Firstly, thank you so very much for your kind replies. You have been
so
> patient and I am very, very grateful for your help.
>
> I have been away and so I'm trying now to gather my thoughts on this
again.
>
> 1) I did read section 7.7 of the MEDIPS manual. My understanding
(correct
> me if I am wrong) is that MEDIPS identifies differentially
methylated
> regions (DMRs) by a sample-against-sample method rather than a
> group-against-group method. So, if I have 5 controls (A,B,C,D,E) and
6
> (1,2,3,4,5,6) test samples, then EACH individual control sample is
compared
> against EACH test sample. So, A vs. 1, A vs. 2, A vs. 3, A vs. 4, A
vs. 5,
> A vs. 6, B vs. 1, B vs. 2, ......etc. instead of comparing ALL of
the
> control samples against ALL of the test samples. Is my understanding
> correct?
>
> No that is not correct. MEDIPS identifies differentially enriched
regions
> by comparing two groups of samples.
>
> You are therefore saying that because of this all-against-all method
that
> MEDIPS uses, correcting for CpG density is actually not necessary.
But
> that's for identifying differentially methylated regions in MEDIPS.
I don't
> quite understand how this relates to my Principal Component Analysis
since
> I believe that I need to export my data out from MEDIPS and maybe
use a
> different R package to do the PCA. So I am guessing that I need to
export
> the methylation profile files for each sample and then input them
into the
> PCA analysis software.
>
> The motivation of CpG normalization is to quantify MeDIP signals at
> genomic regions with varying CpG density across a genome. The
differential
> enrichment analysis compares IP-seq derived signals at genomic
windows
> across samples. Therefore, the signal for a specific window will not
be
> affected by different CpG densities across samples. The same
assumption
> applies when you are comparing different samples with each other
employing
> PCA. Due to a lack of experience I cannot recommend to use CpG
normalized
> methylation estimates or for example variance stabilized counts as
done by
> DESeq for RNA-seq data.
>
>
> 2) I have decided to try and do a PCA/hierarchical clustering using
only
> the methylation levels of a specific genomic feature (eg. all gene
> promoters) to make things simple. I have decided to take your
suggestion. I
> believe I can use the MEDIPS.createROIset() to calculate the
methylation
> levels at all gene promoters. I can then use the methylation profile
for
> the ROI (in this case, promoter) from each sample to do a a
hierarchical
> clustering or PCA.
>
> 3) You said: " In case you want to apply a PCA on CpG density
methylation
> estimates anyway, you can either use the rms values
......."...however, I
> still don't know if RMS is a linear or logarithmic value. If I have
4
> 100-bp windows where the RMS is 3, 5, 8, 9, can I say that the RMS
for the
> this 400-bp region is 25? If RMS is a log value then obviously I
cannot
> just add them up.
> The rms values are not log transformed. However, the signals in
> neighbouring windows are not independent. Extended reads spanning
more than
> one window will be counted several times. Therefore, adding up
counts or
> rms values is not valid. You can use MEDIPS.createROIset() instead.
>
> 4) Also, I was looking at the methylation profile file and I noticed
that
> some RMS values are given as "Inf" or "NA". I am confused as to how
to use
> or interpret this. I also don't understand why it is "NA"...why not
just
> put a 0 (zero) instead of an "NA"?
> What are the CF and count values for windows where rms values are NA
or
> Inf? Can you send examples?
>
> 5) Thanks for the suggestion to use the MEDIPS.meth() function to
remove
> windows with low or zero counts. That's really helpful. I hadn't
even
> considered that.
>
> Have a great weekend.
>
> Warmest regards,
> Allen
>
>
>
>
> ________________________________________
> From: Lukas Chavez [lukas.chavez.mailings@googlemail.com<mailto:> lukas.chavez.mailings@googlemail.com>]
> Sent: Tuesday, September 09, 2014 1:09 AM
> To: Chong Kim San Allen
> Cc: Allen [guest]; bioconductor@r-project.org<mailto:> bioconductor@r-project.org>; MEDIPS Maintainer
> Subject: Re: [BioC] MEDIPS: how does MEDIPS define a methylated
region /
> cluster?
>
> Dear Allen,
>
> I was referring to section 7.7 of the MEDIPS Tutorial (or vignette)
> available at:
>
>
http://www.bioconductor.org/packages/release/bioc/vignettes/MEDIPS/i
nst/doc/MEDIPS.pdf
>
> I recommend to apply the a PCA to the counts at the genomic windows
> returned by the MEDIPS.meth() function where you probably want to
remove
> windows with zero or low counts first. Here, the assumption is that
CpG
> density correction of MeDIP signals might not be necessary as you
are
> comparing different samples with each other (please see section 7.7
of the
> MEDIPS tutorial). In case you want to apply a PCA on CpG density
> methylation estimates anyway, you can either use the rms values or
> calculate methylation estimates using BayMeth, a recent tool that
appears
> to be superior for such methylation estimates.
>
> All the best,
> Lukas
>
> On Sun, Sep 7, 2014 at 11:10 AM, Chong Kim San Allen
<patcksa@nus.edu.sg> <mailto:patcksa@nus.edu.sg><mailto:patcksa@nus.edu.sg<mailto:> patcksa@nus.edu.sg>>> wrote:
> Dear Lukas,
> Again, I am so grateful for your quick reply.
>
> The only manual for MEDIPS that I know of is this one:
>
http://www.bioconductor.org/packages/release/bioc/manuals/MEDIPS/man
/MEDIPS.pdf
> and I have looked and just can't find the section 7.7 that you
mentioned.
>
> The reason I asked about how MEDIPS defines a cluster is because I
wanted
> to try and reduce the number of methylated regions that I look at
and then
> use these "consolidated" regions to do a principal component
analysis
> (PCA). I have 12 cell types and I wanted to see if I could either do
a PCA
> or Unsupervised Hierarchical Clustering to separate these 12 cell
types
> into subgroups, based on their methylation profile.
>
> You said: "When windows with significant differential enrichment
between
> groups have been identified, the MEDIPS.mergeFrames() function can
be used
> to merge adjacent significant windows into extended regions."
> But at this point, I don't have any groupings. Normally, one would
have a
> control and test group and so you can do what you suggested. But I
have
> only, for example, a test group and I want to know if this test
group can
> be further subdivided into a few subgroups based on their
methylation
> profile. I would think that it would be computationally intensive if
I used
> original 100bp windows generated by MEDIPS and entered all the rms
values
> for each window of each cell type into the PCA.
>
> You said: "Instead of merging any values across windows, I recommend
to
> make use of the MEDIPS.createROIse() function which allows for
analyzing
> specific regions of interest."
> I didn't want my PCA analysis to be biased by a predefined "region
of
> interest", be it whether the ROI is a promoter, CpG, etc. I wanted
to just
> input the raw methylation scores (rms) to see what I could get. So
that is
> why I asked if the rms can be added up (in question 4 of my last
> email)...also I was curious if it could be done.
>
> Once again., thanks so very much for taking time from your busy
schedule
> to answer my questions.
>
> Best regards,
> Allen
>
> ________________________________________
> From: Lukas Chavez [lukas.chavez.mailings@googlemail.com<mailto:> lukas.chavez.mailings@googlemail.com><mailto:> lukas.chavez.mailings@googlemail.com<mailto:> lukas.chavez.mailings@googlemail.com>>]
> Sent: Saturday, September 06, 2014 11:09 AM
> To: Allen [guest]
> Cc:
bioconductor@r-project.org<mailto:bioconductor@r-project.org><mailto:> bioconductor@r-project.org<mailto:bioconductor@r-project.org>>;
Chong Kim
> San Allen; MEDIPS Maintainer
> Subject: Re: [BioC] MEDIPS: how does MEDIPS define a methylated
region /
> cluster?
>
> Dear Allen,
>
> please see my comments below. Moreover, please consider reading
section
> 7.7 of the MEDIPS manual.
>
> Best,
> Lukas
>
>
> On Fri, Sep 5, 2014 at 1:14 AM, Allen [guest]
<guest@bioconductor.org>
<mailto:guest@bioconductor.org><mailto:guest@bioconductor.org<mailto:> guest@bioconductor.org>><mailto:guest@bioconductor.org<mailto:> guest@bioconductor.org><mailto:guest@bioconductor.org<mailto:> guest@bioconductor.org>>>> wrote:
> Hi,
> I have aligned my sequencing data for one sample (filename:
Ca2_MAPQ20.bam
> --- because I filtered out everything with MAPQ20 or less) and I've
put it
> through MEDIPS. At the moment, I am not making a comparison between
> samples. Therefore, the result file shows the methylation profile
for only
> one sample. In this results file, I noticed that the data is
organized as
> such:
> chr start stop CF Ca2_MAPQ20.bam.counts
> Ca2_MAPQ20.bam.rpkm Ca2_MAPQ20.bam.rms Ca2_MAPQ20.bam.prob
> MSets1.counts.mean MSets1.rpkm.mean MSets1.rms.mean
> MSets1.prob.mean
>
> 1) I tried reading the Down et al. (2008) paper that explains the
concept
> of coupling factor and I think it is, simply put, a measure of local
CpG
> density. I am not sure if my understanding of 'coupling factor' is
correct?
>
> That is correct.
>
> 2) This lead to question how or what MEDIPS defines as a "region or
> cluster"? That is to say, on Chromosome 1, I have reads aligning
from
> position "1002501" to "1003300" but then there is a region of 1400
bp (from
> "1003301" to "1004700") where there are no reads aligned (rpkm = 0).
Then,
> again, from "1004701" to "1005400", there reads aligning to this
region. So
> my question is does MEDIPS consider this to be a case of 2
methylated
> regions, that is, "1002501-1003300" and "1004701-1005400" or does
MEDIPS
> try to consolidate these 2 methylated regions into one methylated
> region/cluster (that is, from "1002501-1005400") since they are
fairly
> close to one another.
>
> Each window is considered as one region; CpG density, counts, rpkm,
rms,
> and differential coverage will be calculated for each window
separately.
> When windows with significant differential enrichment between groups
have
> been identified, the MEDIPS.mergeFrames() function can be used to
merge
> adjacent significant windows into extended regions.
>
> 3) I used "uniq=TRUE" to get rid of stacked/clonal reads and so for
each
> 100 bp bin, I am usually getting rpkm=1 within each bin but
occasionally,
> it may be as many rpkm=3. This lead me to wonder how the relative
> methylation score ("Ca2_MAPQ20.bam.rms") is calculated? For example,
3 bins
> have a value of 1 rpkm each, but one has an rms value of
"1660.409928",
> another an rms of "7122.10254" and the third is only "679.1814523".
How is
> that possible that 3 bins that have the same rpkm can have such
varying rms
> values?
>
> This is due to the different CpG densities in these windows.
>
> 4)Can the rms be added up for a region so as to represent the
cumulative
> methylation level for that region. I am asking because I do not know
if the
> rms value is a log value or what? So, in my above question (3), if
the 3
> bins are adjacent to one another and I decide to cluster them
together and
> consider them as one methylated region, then would the rms value for
this
> new 300bp bin that I have created be 1660.409928 + 7122.10254 +
679.1814523
> = 9461.68.
>
> Instead of merging any values across windows, I recommend to make
use of
> the MEDIPS.createROIse() function which allows for analyzing
specific
> regions of interest.
>
> 5)Finally, what does "Ca2_MAPQ20.bam.prob" represent? I figured that
is
> some sort of a probability score but I am not sure of what.
>
> As mentioned in the manual, please disregard the prob values which
will be
> removed in a future version.
>
> Thanks in advance for any assistance in answering my questions.
>
> Best regards,
> Allen
>
> -- output of sessionInfo():
>
> error
>
> --
> Sent via the guest posting facility at bioconductor.org<
>
http://bioconductor.org><http: bioconductor.org=""><http: bioconducto="" r.org=""> >.
>
> _______________________________________________
> Bioconductor mailing list
>
Bioconductor@r-project.org<mailto:bioconductor@r-project.org><mailto:>
Bioconductor@r-project.org<mailto:bioconductor@r-project.org>><mailto:>
Bioconductor@r-project.org<mailto:bioconductor@r-project.org><mailto:> Bioconductor@r-project.org<mailto:bioconductor@r-project.org>>>
>
https://stat.ethz.ch/mailman/listinfo/bioconductor
> Search the archives:
>
http://news.gmane.org/gmane.science.biology.informatics.conductor
>
> Important: This email is confidential and may be privileged. If you
are
> not the intended recipient, please delete it and notify us
immediately; you
> should not copy or use it for any purpose, nor disclose its contents
to any
> other person. Thank you.
>
> Important: This email is confidential and may be privileged. If you
are
> not the intended recipient, please delete it and notify us
immediately; you
> should not copy or use it for any purpose, nor disclose its contents
to any
> other person. Thank you.
>
>
> Important: This email is confidential and may be privileged. If you
are
> not the intended recipient, please delete it and notify us
immediately; you
> should not copy or use it for any purpose, nor disclose its contents
to any
> other person. Thank you.
>
[[alternative HTML version deleted]]
_______________________________________________
Bioconductor mailing list
Bioconductor@r-project.org
https://stat.ethz.ch/mailman/listinfo/bioconductor
Search the archives:
http://news.gmane.org/gmane.science.biology.informatics.conductor